ZhenFund — 2021 Investments
3 investments dated 2021 · listed companies and verified rows first · show all
Accutar Biotech applies artificial intelligence to drug discovery, using a hybrid approach of computational drug design followed by wet lab validation to reduce the time and cost of developing new drugs.
AI & Machine LearningBiotechDeep TechNew York, US
Jie Fan(Founder)inWei He(Executive Officer)Yimin Qian(Executive Officer)Xiangyan Sun(Executive Officer)Quan Zhou(Director)Long Zhu(Director)
Co-investors5Y CapitalCoatue ManagementIDG CapitalYF Capital
CellX offers a self-service operations management platform that automates repetitive tasks such as 24/7 order intake, multi-channel order and message handling, order status tracking, and after-sales ticket workflows.
E-commerceEnterprise SoftwareSaaS
Ziliang Yang(Founder)in
Co-investorsBetter Bite VenturesSky9 CapitalAgronomicsLever VCSALT
Software platform to improve drug discovery
AI & Machine LearningBiotechDeep TechNew York, US
David William Rooklin(Executive Officer, Director)Haotian Li(Director)
Co-investorsCollaborative FundHAWKTAILNotation CapitalNYU Innovation Venture FundAcequia Capital (AceCap)Preface Ventures+2 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.












